Proinflammatory phenotype and increased caveolin-1 in alveolar macrophages with silenced CFTR mRNA
- PMID: 20543983
- PMCID: PMC2882373
- DOI: 10.1371/journal.pone.0011004
Proinflammatory phenotype and increased caveolin-1 in alveolar macrophages with silenced CFTR mRNA
Abstract
The inflammatory milieu in the respiratory tract in cystic fibrosis (CF) has been linked to the defective expression of the cystic transmembrane regulator (CFTR) in epithelial cells. Alveolar macrophages (AM), important contibutors to inflammatory responses in the lung, also express CFTR. The present study analyzes the phenotype of human AM with silenced CFTR. Expression of CFTR mRNA and the immature form of the CFTR protein decreased 100-fold and 5.2-fold, respectively, in AM transfected with a CFTR specific siRNA (CFTR-siRNA) compared to controls. Reduction of CFTR expression in AM resulted in increased secretion of IL-8, increased phosphorylation of NF-kappaB, a positive regulator of IL-8 expression, and decreased expression of IkappaB-alpha, the inhibitory protein of NF-kappaB activation. AM with silenced CFTR expression also showed increased apoptosis. We hypothesized that caveolin-1 (Cav1), a membrane protein that is co-localized with CFTR in lipid rafts and that is related to inflammation and apoptosis in macrophages, may be affected by decreased CFTR expression. Messenger RNA and protein levels of Cav1 were increased in AM with silenced CFTR. Expression and transcriptional activity of sterol regulatory element binding protein (SREBP), a negative transcriptional regulator of Cav1, was decreased in AM with silenced CFTR, but total and free cholesterol mass did not change. These findings indicate that silencing of CFTR in human AM results in an inflammatory phenotype and apoptosis, which is associated to SREBP-mediated regulation of Cav1.
Conflict of interest statement
Figures





Similar articles
-
Influence of the cystic fibrosis transmembrane conductance regulator on expression of lipid metabolism-related genes in dendritic cells.Respir Res. 2009 Apr 3;10(1):26. doi: 10.1186/1465-9921-10-26. Respir Res. 2009. PMID: 19344509 Free PMC article.
-
Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa.Am J Physiol Cell Physiol. 2009 Aug;297(2):C263-77. doi: 10.1152/ajpcell.00527.2008. Epub 2009 Apr 22. Am J Physiol Cell Physiol. 2009. PMID: 19386787 Free PMC article.
-
Effects of the serine/threonine kinase SGK1 on the epithelial Na(+) channel (ENaC) and CFTR: implications for cystic fibrosis.Cell Physiol Biochem. 2001;11(4):209-18. doi: 10.1159/000051935. Cell Physiol Biochem. 2001. PMID: 11509829
-
Disease-causing mutations in the cystic fibrosis transmembrane conductance regulator determine the functional responses of alveolar macrophages.J Biol Chem. 2009 Dec 18;284(51):35926-38. doi: 10.1074/jbc.M109.057372. J Biol Chem. 2009. PMID: 19837664 Free PMC article.
-
Cystic fibrosis and the use of pharmacogenomics to determine surrogate endpoints for drug discovery.Am J Pharmacogenomics. 2001;1(3):223-38. doi: 10.2165/00129785-200101030-00006. Am J Pharmacogenomics. 2001. PMID: 12083969 Review.
Cited by
-
Exploring YAP1-centered networks linking dysfunctional CFTR to epithelial-mesenchymal transition.Life Sci Alliance. 2022 May 2;5(9):e202101326. doi: 10.26508/lsa.202101326. Print 2022 Sep. Life Sci Alliance. 2022. PMID: 35500936 Free PMC article.
-
CFTR regulates B cell activation and lymphoid follicle development.Respir Res. 2019 Jul 1;20(1):133. doi: 10.1186/s12931-019-1103-1. Respir Res. 2019. PMID: 31262295 Free PMC article.
-
Down-regulation of cytokine-induced interleukin-8 requires inhibition of p38 mitogen-activated protein kinase (MAPK) via MAPK phosphatase 1-dependent and -independent mechanisms.J Biol Chem. 2011 May 6;286(18):15998-6007. doi: 10.1074/jbc.M110.205724. Epub 2011 Mar 15. J Biol Chem. 2011. PMID: 21454676 Free PMC article.
-
Role of caveolin-3 in lymphocyte activation.Life Sci. 2015 Jan 15;121:35-9. doi: 10.1016/j.lfs.2014.11.017. Epub 2014 Dec 2. Life Sci. 2015. PMID: 25476831 Free PMC article.
-
Ceramide in cystic fibrosis: a potential new target for therapeutic intervention.J Lipids. 2011;2011:674968. doi: 10.1155/2011/674968. Epub 2010 Dec 28. J Lipids. 2011. PMID: 21490807 Free PMC article.
References
-
- Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, et al. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 1995;151:1075–1082. - PubMed
-
- Jacquot J, Tabary O, Le Rouzic P, Clement A. Airway epithelial cell inflammatory signalling in cystic fibrosis. Int J Biochem Cell Biol. 2008;40:1703–1715. - PubMed
-
- Brennan S. Innate immune activation and cystic fibrosis. Paediatr Respir Rev. 2008;9:271–280. - PubMed
-
- McDonald TV, Nghiem PT, Gardner P, Martens CL. Human lymphocytes transcribe the cystic fibrosis transmembrane conductance regulator gene and exhibit CF-defective cAMP-regulated chloride current. J Biol Chem. 1992;267:3242–3248. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources